Skip to main content
Pulike Biological Engineering,Inc. logo

Pulike Biological Engineering,Inc. — Investor Relations & Filings

Ticker · 603566 ISIN · CNE1000025N0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,080 across all filing types
Latest filing 2023-04-25 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 603566

About Pulike Biological Engineering,Inc.

http://en.pulike.com.cn/

Pulike Biological Engineering, Inc. specializes in the research, development, and production of veterinary biological products and pharmaceutical preparations. The company focuses on animal disease prevention through the manufacture of high-end vaccines, diagnostic reagents, and veterinary medicines. Its product range primarily serves the swine and poultry sectors, featuring advanced biologicals such as genetically engineered vaccines and synthetic peptide products. Pulike maintains a strong emphasis on technological innovation, utilizing national-level research platforms to develop solutions for complex animal health challenges. The company’s core activities encompass the entire value chain from basic biotechnology research to the commercialization of veterinary health solutions, aiming to improve livestock productivity and biosecurity.

Recent filings

Filing Released Lang Actions
普莱柯审计委员会2022年度履职情况报告
Audit Report / Information Classification · 95% confidence The document is a detailed report from the Board Audit Committee of 普莱柯生物工程股份有限公司 for the year 2022. It discusses the committee's activities, including supervision of external auditors, review of financial reports, internal audit work, and internal control effectiveness. The content focuses on audit committee duties and oversight rather than presenting standalone audit opinions or accounting principles. The document length is 2418 characters, which is relatively short but contains substantive content about audit committee work rather than just an announcement. It is not a full Annual Report (10-K) or an Audit Report (AR) in the strict sense, but rather a report on the audit committee's performance and activities. This fits best under Audit Report / Information (AR) as it relates to audit committee oversight and audit-related information, distinct from full annual reports or regulatory filings. Therefore, the classification is AR with high confidence. FY 2022
2023-04-25 Chinese
普莱柯2022年度报告
Annual Report Classification · 100% confidence The document is titled '2022 年年度报告' which translates to '2022 Annual Report'. It contains detailed sections typical of an annual report such as company overview, financial data, management discussion and analysis, corporate governance, environmental and social responsibility, and audited financial statements. The document includes signatures from the legal representative and accounting officers, and mentions an unqualified audit opinion from a certified public accounting firm. The length is substantial (15,000 characters) and it contains comprehensive financial and operational information for the full fiscal year 2022. These characteristics align with the definition of an Annual Report (10-K). FY 2022
2023-04-25 Chinese
关于使用部分暂时闲置自有资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by a company regarding the use of temporarily idle funds for cash management, including details about the amount, duration, types of financial products, risk control measures, and approvals by the board and independent directors. It does not contain financial statements or detailed financial performance data. It is a regulatory announcement about financing activities related to cash management, not a full financial report or earnings release. Therefore, it fits best under Capital/Financing Update (CAP). The document length is short and focused on a specific financing-related activity, confirming this classification.
2023-04-25 Chinese
普莱柯2022年审计报告
Regulatory Filings
2023-04-25 Chinese
普莱柯2022年度内部控制评价报告
Audit Report / Information Classification · 95% confidence The document is titled '2022年度内部控制评价报告' which translates to '2022 Annual Internal Control Evaluation Report'. It discusses the evaluation of the company's internal control effectiveness as of December 31, 2022, including financial and non-financial internal control defects, their identification, and rectification status. The content is focused on internal control evaluation rather than full financial statements or audit opinions alone. It is not an Annual Report (10-K) or Audit Report (AR) but a specialized internal control evaluation report. This type of document fits best under the category of Audit Report / Information (AR), as it is a standalone report on internal control evaluation and related audit opinions, not a full annual report or other category. The document length (4710 characters) and detailed content support this classification with high confidence. FY 2022
2023-04-25 Chinese
普莱柯2022年度募集资金存放与使用情况的鉴证报告
Regulatory Filings
2023-04-25 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.